1
|
Khan MI, Choudhry H, Jahan S, Rather IA. Reversal of Azole Resistance in Candida albicans by Human Neutrophil Peptide. Biomedicines 2023; 11. [PMID: 36831048 DOI: 10.3390/biomedicines11020513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2023] [Revised: 02/01/2023] [Accepted: 02/08/2023] [Indexed: 02/12/2023] Open
Abstract
With the spread of AIDS and the increase in immunocompromised patients, multi-drug-resistant fungal infections have become a serious concern among clinicians, predominantly in the developing world. Therefore, developing novel strategies and new drugs is essential to overcome drug resistance in fungal pathogens. Antimicrobial peptides of human origin have been investigated as a potential treatment against Candida infections. In this study, human neutrophil peptide (HNP) was tested for its antifungal activity alone and in combination with fluconazole (FLC) against azole-susceptible and resistant C. albicans isolates, following CLSI guidelines. Susceptibility and combination interactions were also confirmed by MUSE cell viability assay and isobolograms for synergistic combinations, respectively. The effect of HNP on biofilm inhibition was determined spectrophotometrically and microscopically. Drug susceptibility testing showed minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) ranging from 7.813 to 62.5 µg/mL and 15.625 to 250 µg/mL against all the tested C. albicans strains. The combination activity of FLC with HNP exhibited synergistic and additive interactions in 43% of each and indifferent interaction in 14%, and none of the combinations showed antagonistic interaction. Furthermore, HNB inhibited biofilm formation in all the tested C. albicans isolates. At the respective MICs, HNP exhibited inhibitory effects on the activity of the drug efflux pumps and their genes. These results warrant the application of HNP as a mono- or combination therapy with FLC to treat azole-resistant C. albicans.
Collapse
|
2
|
Valle-Jiménez X, Ramírez-Cosmes A, Aquino-Domínguez AS, Sánchez-Peña F, Bustos-Arriaga J, Romero-Tlalolini MDLÁ, Torres-Aguilar H, Serafín-López J, Aguilar Ruíz SR. Human platelets and megakaryocytes express defensin alpha 1. Platelets 2019; 31:344-354. [PMID: 31116063 DOI: 10.1080/09537104.2019.1615612] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Platelets are anucleate cells that have a role in several innate immune functions, including the secretion of proteins with antimicrobial activity. Several studies have demonstrated the ability of platelets to secrete thrombin-induced platelet microbicidal proteins and antimicrobial peptides, like hBD-1. However, the expression and secretion of defensins of the alpha family by platelets have not been fully elucidated. The aim of this study was to characterize the expression of defensin alpha 1 (DEFA1) in human platelets and megakaryocytes. Our data indicate that DEFA1 mRNA and protein are present in peripheral blood platelets and in the megakaryoblastic leukemia cell line (MEG-01). DEFA1 co-localize with α-granules of platelets and MEG-01 cells, and was also detected in cytoplasm of MEG-01 cells. The assay of our in vitro model of platelet-like particles (PLPs) revealed that MEG-01 cells could transfer DEFA1 mRNA to their differentiated PLPs. Furthermore, platelets secreted DEFA1 into the culture medium when activated with thrombin, adenosine diphosphate, and lipopolysaccharide; meanwhile, MEG-01 cells secreted DEFA1 when activated with thrombopoietin. Platelet's secreted DEFA1 can rebind to platelet's surface and have antibacterial activity against the gram-negative bacteria Escherichia coli. In summary, our data indicate that both, human platelets and megakaryocytes, can express and secrete DEFA1. These results suggest a new role of platelets and megakaryocytes in the innate immune response.
Collapse
Affiliation(s)
- Xareni Valle-Jiménez
- Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas (ENCB), Instituto Politécnico Nacional (IPN), ENCB-IPN, Ciudad de México, México.,Departamento de Biomedicina Experimental, Facultad de Medicina y Cirugía de la Universidad Autónoma 'Benito Juárez' of Oaxaca, Oaxaca, México
| | - Adriana Ramírez-Cosmes
- Departamento de Biomedicina Experimental, Facultad de Medicina y Cirugía de la Universidad Autónoma 'Benito Juárez' of Oaxaca, Oaxaca, México
| | - Alba Soledad Aquino-Domínguez
- Departamento de Biomedicina Experimental, Facultad de Medicina y Cirugía de la Universidad Autónoma 'Benito Juárez' of Oaxaca, Oaxaca, México
| | - Francisco Sánchez-Peña
- Departamento de Biomedicina Experimental, Facultad de Medicina y Cirugía de la Universidad Autónoma 'Benito Juárez' of Oaxaca, Oaxaca, México
| | - José Bustos-Arriaga
- Laboratorio de Biología Molecular e Inmunología de Arbovirus, Unidad de Biomedicina, Facultad de Estudios Superiores - Iztacala de la Universidad Autónoma Nacional de México, Tlalnepantla de Baz, Estadode México, México
| | | | - Honorio Torres-Aguilar
- Facultad de Ciencias Químicas, Universidad Autónoma 'Benito Juárez' de Oaxaca, Oaxaca, México
| | - Jeanet Serafín-López
- Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas (ENCB), Instituto Politécnico Nacional (IPN), ENCB-IPN, Ciudad de México, México
| | - Sergio Roberto Aguilar Ruíz
- Departamento de Biomedicina Experimental, Facultad de Medicina y Cirugía de la Universidad Autónoma 'Benito Juárez' of Oaxaca, Oaxaca, México
| |
Collapse
|
3
|
Cardot-Martin E, Casalegno JS, Badiou C, Dauwalder O, Keller D, Prévost G, Rieg S, Kern WV, Cuerq C, Etienne J, Vandenesch F, Lina G, Dumitrescu O. α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureus. Lett Appl Microbiol 2015; 61:158-64. [PMID: 25963798 DOI: 10.1111/lam.12438] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2015] [Revised: 04/30/2015] [Accepted: 05/02/2015] [Indexed: 01/15/2023]
Abstract
UNLABELLED α-Defensins produced by neutrophils are important effector molecules of the innate immune system. In addition to their microbicidal effects, α-defensins have the ability to neutralize bacterial toxins. Panton-Valentine leukocidin (PVL) is the hallmark of community-acquired methicillin-resistant Staphylococcus aureus. Staphylococcus aureus that produce PVL are responsible for severe diseases, including necrotizing pneumonia. Polymorphonuclear neutrophils (PMNs) are the target cells of PVL action. The goal of this study was to elucidate the effect of a group of α-defensins known as the human neutrophil peptides (HNPs) on the interactions between LukS-PV and LukF-PV, which compose PVL, and human PMNs. We observed that HNPs bound to both subunits of PVL and significantly decreased PVL pore formation in PMNs, with a maximum inhibition of 27%. When various HNP molecules were tested individually under the same conditions, we observed that HNP3, but not HNP1 or 2, decreased pore formation. Similarly, HNP3 significantly decreased PVL-induced PMN lysis, with a maximum inhibition of 31%. Interestingly, HNPs did not affect LukS-PV LukF-PV oligomerization, LukS-PV LukF-PV binding to PMNs or calcium influx induced by PVL in PMNs. Our results suggest that HNP3 partially protects neutrophils against PVL by interfering with the conformational changes of PVL required to form a functional pore. SIGNIFICANCE AND IMPACT OF THE STUDY Panton-Valentine leukocidin (PVL) is a pore-forming toxin produced by Staphylococcus aureus, responsible for neutrophil damage and key player of severe staphylococcal diseases. Antimicrobial peptides produced by neutrophils (HNP1-3) neutralize several other bacterial cytotoxins. We examined the impact of human neutrophil peptides (HNPs) on PVL cytotoxicity against human neutrophils and we found that HNPs bind to both LukS and LukF components of PVL, thereby inhibiting pore formation and neutrophil lysis. Our results suggest that HNP3 may impair PVL conformational changes required to form a functional pore and provide insight into the pathogenesis of PVL-related staphylococcal infection, with potential impact on the disease outcome.
Collapse
Affiliation(s)
- E Cardot-Martin
- Centre International de Recherche en Infectiologie, INSERM U1111, University of Lyon 1, Lyon, France.,Hospices Civils de Lyon, Lyon, France
| | | | - C Badiou
- Centre International de Recherche en Infectiologie, INSERM U1111, University of Lyon 1, Lyon, France.,Hospices Civils de Lyon, Lyon, France
| | - O Dauwalder
- Centre International de Recherche en Infectiologie, INSERM U1111, University of Lyon 1, Lyon, France.,Hospices Civils de Lyon, Lyon, France
| | - D Keller
- Department of Microbiology, University of Strasbourg, Strasbourg, France
| | - G Prévost
- Department of Microbiology, University of Strasbourg, Strasbourg, France
| | - S Rieg
- Center for Infectious Diseases and Travel Medicine, University Medical Center, Freiburg, Germany
| | - W V Kern
- Center for Infectious Diseases and Travel Medicine, University Medical Center, Freiburg, Germany
| | - C Cuerq
- Hospices Civils de Lyon, Lyon, France.,Laboratoire de Biochimie, Centre de Biologie Sud, Lyon, France
| | - J Etienne
- Centre International de Recherche en Infectiologie, INSERM U1111, University of Lyon 1, Lyon, France.,Hospices Civils de Lyon, Lyon, France
| | - F Vandenesch
- Centre International de Recherche en Infectiologie, INSERM U1111, University of Lyon 1, Lyon, France.,Hospices Civils de Lyon, Lyon, France
| | - G Lina
- Centre International de Recherche en Infectiologie, INSERM U1111, University of Lyon 1, Lyon, France.,Hospices Civils de Lyon, Lyon, France
| | - O Dumitrescu
- Centre International de Recherche en Infectiologie, INSERM U1111, University of Lyon 1, Lyon, France.,Hospices Civils de Lyon, Lyon, France
| |
Collapse
|
4
|
Abstract
Defensins are an effector component of the innate immune system with broad antimicrobial activity. Humans express two types of defensins, α- and β-defensins, which have antiviral activity against both enveloped and non-enveloped viruses. The diversity of defensin-sensitive viral species reflects a multitude of antiviral mechanisms. These include direct defensin targeting of viral envelopes, glycoproteins, and capsids in addition to inhibition of viral fusion and post-entry neutralization. Binding and modulation of host cell surface receptors and disruption of intracellular signaling by defensins can also inhibit viral replication. In addition, defensins can function as chemokines to augment and alter adaptive immune responses, revealing an indirect antiviral mechanism. Nonetheless, many questions regarding the antiviral activities of defensins remain. Although significant mechanistic data are known for α-defensins, molecular details for β-defensin inhibition are mostly lacking. Importantly, the role of defensin antiviral activity in vivo has not been addressed due to the lack of a complete defensin knockout model. Overall, the antiviral activity of defensins is well established as are the variety of mechanisms by which defensins achieve this inhibition; however, additional research is needed to fully understand the role of defensins in viral pathogenesis.
Collapse
Affiliation(s)
| | | | - Jason G. Smith
- University of Washington School of Medicine, Box 357735, 1705 North East Pacific Street, Seattle, WA 98195, USA
| |
Collapse
|